Forth, anti-neoplastic cytotoxicity of gemcibatine-(C4-amide)-[anti-HER2/neu] immunochemotherapeutic could have been delineated in-vivo against human neoplastic xenographs in animal hosts as a model for human cancer. This evidence concerns the gene ERBB2 and cancer.